−50.7
Olema Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−82.1
FY23:
−83.7
FY24:
−104
FY25:
−147
Change from FY21 to FY25
millions USD
FY21:
−275
FY22:
91.5
FY23:
−4.85
FY24:
−93.5
FY25:
−156
Change from FY21 to FY25
millions USD
FY21:
1.39
FY22:
0.48
FY23:
133
FY24:
269
FY25:
211
millions USD
FY21:
−325
FY22:
9.89
FY23:
44.8
FY24:
70.9
FY25:
−91.2
(positive)
Change from FY21 to FY24
millions USD
FY21:
−52.3
FY22:
−82.4
FY23:
–
FY24:
−105
FY25:
–
All amounts in millions USD